Opinion

Tell me the whole story: the role of product labelling in building user confidence in biosimilars in Europe

Published in: Volume 3 / Year 2014 / Issue 4
Author(s):
Page: 188-92

Abstract: The European Medicines Agency (EMA) has led the development of biosimilar regulatory pathways globally, tailoring their approach to meet the specific and scientifically determined needs of biosimilar development. However,… Read More »

Pathway to affordable, quality-assured sources of pegylated interferon alpha for treating hepatitis C

Published in: Volume 2 / Year 2013 / Issue 4
Author(s): ,
Page: 194-203

Author byline as per print journal: Barbara Milan, Sara Gaspani Introduction: The current pipeline of promising oral hepatitis C drugs could lead to a revolution in treatment for this disease… Read More »

Page 2 of 2 « Previous1 2
Go Back Print